Helicobacter pylori strikes again: Gastric mucosa-associated lymphoid tissue (MALT) lymphoma

Gastroenterology Nursing

Volumn 30, Issue 5, 2007, Pages 348-354

  Swisher, Stephenie C ^a   Barbati, Alfonso J ^a  

^a Mercy Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIULCER AGENT; PROTON PUMP INHIBITOR;

AFTERCARE; CANCER STAGING; DRUG COMBINATION; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; GASTRITIS; GASTROSCOPY; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; REVIEW; STOMACH TUMOR;

AFTERCARE; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CAUSALITY; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; GASTRITIS; GASTROSCOPY; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; NEOPLASM STAGING; PROTON PUMP INHIBITORS; STOMACH NEOPLASMS;

EID: 37349024690     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/01.SGA.0000296255.16576.e5     Document Type: Review

References (37)

1. Ahmad, A., Govil, Y., & Frank, B. (2003). Gastric mucosa-associated lymphoid tissue lymphoma. American Journal of Gastroenterology, 98, 975-986.
2. Al-Akwaa, A., Siddiqui, N., & Al-Mofleh, I. (2004). Primary gastric lymphoma. World Journal of Gastroenterology, 10, 5-11.
3. Atherton, J., & Blaser, M. (2005). Helicobacter pylori infections. In D. Kasper, E. Braunwald, A. Fauci, S. Hauser, D. Longo, & J. Jameson (Eds.), Harrison's principles of internal medicine (16th ed., pp. 886-889). New York: McGraw-Hill.
4. Caletti, G., Zinzani, P., Fusaroli, P., Buscarini, E., Parente, F., Federici, T., et al. (2002). The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma. Alimentary Pharmacology & Therapeutics, 16, 1715-1722.
5. Chen, L., Lin J., Tai, J., Chen, G., Yeh, H., Yang, S., et al. (2005). Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. Journal of the National Cancer Institute, 97, 1345-1353.
6. Du, M., & Isaccson, P. (2002). Gastric MALT lymphoma: From aetiology to treatment. Lancet, 3, 97-104.
7. Farinha, P., & Gascoyne, R. (2005). Helicobacter pylori and MALT lymphoma. Gastroenterology, 128, 1579-1605.
8. Fischbach, L., Goodman, K., Feldman, M., & Aragaki, C. (2002). Sources of variation of Helicobacter pylori treatment success in adults worldwide: A meta-analysis. International Journal of Epidemiology, 31, 128-139.
9. Fischbach, W., Goebeler-Kolve, M.-E., Dragosics, B., Greiner, A., & Stolte, M. (2004). Long-term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: Experience from a large prospective series. Gut, 53, 34-37.
10. Huang, Q., Zheng, G., Sumanac, K., Irvine, J., & Hunt, R. (2003). Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology, 125, 1636-1644.
11. Kikuchi, Y., Matsui, T., Hisabe, T., Wada, Y., Hoashi, T., Tsuda, S., et al. (2005). Deep infiltrative low-grade MALT (mucosal-associated lymphoid tissue) colonic lymphomas that regressed as a result of antibiotic administration: Endoscopic ultrasound evaluation. Journal of Gastroenterology, 40, 843-847.
12. Knigge, K. (2001). The role of H. pylori in gastrointestinal disease: A guide to identification and eradication. Post-graduate Medicine, 110(3), 71-72, 77-78, 81-82.
13. Koch, P., del Valle, F., Berdel, W., Willich, N., Reers, B., Hiddemann, W., et al. (2001). Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study (GIT NHL 01/92). Journal of Clinical Oncology, 19, 3861-3873.
14. Lee, S., Lee, Y., Chung, J., Chon, C., Moon Y., Kang, J., et al. (2004). Low-grade gastric MALToma: Treatment strategies based on 10-year follow-up. World Journal of Gastroenterology, 10, 223-226.
15. Lehours, P., Menard A., Dupouy S., Bergey B., Richy F., Zerbib, F., et al. (2004). Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infection & Immunity, 72, 880-888.
16. Lenze, D., Berg, E., Volkmer-Engert, R., Weiser A., Greiner, A., Knorr-Wittmann, C., et al. (2006). Influence of antigen on the development of MALT lymphoma. Blood, 107, 1141-1148.
17. Malaty, W., Stigleman, S., & Hansen, L. B. (2003). What regimens eradicate Helicobacter pylori? Journal of Family Practice, 52, 799-800, 802-803.
18. Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., et al. (2007). Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report. Gut, 56, 772-781.
19. Martin, D. (2006). Atlas of gastrointestinal endoscopy. Retrieved October 7, 2006, from http://www.EndoAtlas.com
20. Mathijs, B., & Marynen, P. (2002). t(11;18)(q21;q21) [Electronic version]. Atlas of Genetics & Cytogenetics in Oncology & Haematology, 6, 88-90. Retrieved June 22, 2006, from http://AtlasGeneticsOncology.org/ Anomalies/t1118ID2022.html
21. McCance, K. L., & Roberts, L. K. (2002). Biology of cancer. In K. L. McCance & S. E. Huether (Eds.), Pathophysiology: The biologic basis for disease in adults and children (4th ed., pp. 312-313). St. Louis, MO: Mosby.
22. McQuaid, K. (2006). Alimentary tract. In L. Tierney, S. McPhee, & M. Papakakis (Eds.), Current medical diagnosis & treatment (45th ed., pp. 598-599). New York: McGraw-Hill.
23. Morgner, A., Miehlke, S., Stolte M., Neubauer, A., Alpen B., Thiede C., et al. (2001). Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World Journal of Gastroenterology, 7, 248-253.
24. Nakamura, S., Matsumoto, T., Suekane, H., Nakamura, S., Hiroshi, M., Esaki, M., et al. (2005). Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer, 104, 532-540.
25. Nakamura, S., Matsumoto, T., Suekane, H., Takeshita, M., Hizawa, K., Kawasaki, M., et al. (2001). Predictive value of endoscopic ultrasonography for regression of gastric low-grade and high-grade MALT lymphomas after eradication of Helicobacter pylori. Gut, 48, 454-460.
26. National Institutes of Health, Consensus Development Panel. (1994). Helicobacter pylori in peptic ulcer disease. Retrieved June 26, 2006, from http://consensus.nih.gov/1994/1994HelicobacterPyloriUlcer094html.htm
27. Neu, B., Rad, R., Reindl, W., Neuhofer, M., Gerhard, M., Schepp, W., et al. (2005). Expression of tumor necrosis factor-alpha-related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains. Journal of Infectious Diseases, 191, 571-578.
28. Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A., Warnke, R., Jellum, E., et al. (1994). Helicobacter pylori infection and gastric lymphoma. New England Journal of Medicine, 330, 1267-1271.
29. Peterson, W., Fendrick, M., Cave, D., Peura, D., Garabedian-Ruffalo, S., & Laine, L. (2000). Helicobacter pylori-related disease: Guidelines for testing and treatment. Archives of Internal Medicine, 160, 1285-1291.
30. Raderer, M., Streubel, B., Wohrer, S., Hafner, M., & Chott, A. (2006). Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut, 55, 616-618.
31. Suerbaum, S., & Michetti, P. (2002). Helicobacter pylori infection. New England Journal of Medicine, 347, 1175-1186.
32. Wong, W., Gu, Q., Chu, K., Yee, Y., Fung, F., Tong, T., et al. (2006). Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics, 23, 421-427.
33. Wotherspoon, A., Ortiz-Hidlago, C., Falzon, M., & Isaacson, P. G. (1991). Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet, 338, 1175-1176.
34. Wundisch, T., Thiede, C., Morgner, A., Dempfle, A., Gunther, A., Liu, H., et al. (2005). Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. Journal of Clinical Oncology, 23, 8018-8024.
35. Ye, H., Liu, H., Attygalle, A., Wotherspoon, A., Nicholson A., Charlotte, A., et al. (2003). Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: Significant association with cagA strains of H. pylori in gastric MALT lymphoma. Blood, 102, 1012-1018.
36. Yeh, H., Chen, G., Chang, W., Poon, S., Yang S., Lien, H., et al. (2003). Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe. Journal of Gastroenterology & Hepatology, 18, 162-167.
37. Zucca, E., Bertoni, F., Roggero, E., & Cavalli, F. (2000). The gastric marginal zone B-cell lymphoma of MALT type. Blood, 96, 410-419.